King Pharma Allocates, Breaks

The $200 million term loan backing King Pharmaceuticals' acquisition of Alpharma allocated and broke for trading Dec. 19.

  • 24 Dec 2008
The $200 million term loan backing King Pharmaceuticals' acquisition of Alpharma allocated and broke for trading Dec. 19. Lead bank Credit Suisse did not put out any levels as it was mainly marketed to banks during syndication. "It's held mostly by banks, so I don't imagine it will ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Total Volume $m No. of Deals Share % by Volume
1 Bank of America Merrill Lynch (BAML) 7,026 25 11.95
2 Citi 6,449 21 10.96
3 BNP Paribas 5,093 18 8.66
4 Barclays 4,040 11 6.87
5 Lloyds Bank 3,615 14 6.15

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 2,384.00 8 11.97%
2 JPMorgan 1,441.26 6 7.24%
3 Bank of America Merrill Lynch 1,369.03 6 6.87%
4 Mizuho 1,358.38 4 6.82%
5 SG Corporate & Investment Banking 1,292.64 1 6.49%